STAT3 and hepatocellular carcinoma: As STAT3 is a well-known oncoprotein that is persistently activated in many cancers, including HCC (He and Karin, 2011; Yu et al., 2009), our findings suggest that repressing STAT3 phosphorylation may be another mechanism that is essential for miR-122 to suppress tumorigenesis.